Hyperbaric oxygen induces apoptosis via a mitochondrial mechanism

Apoptosis

Volumn 14, Issue 1, 2009, Pages 97-107

  Weber, Stefan U ^a   Koch, Andreas ^b   Kankeleit, Jens ^a   Schewe, Jens Christian ^a   Siekmann, Ullrich ^c   Stüber, Frank ^d   Hoeft, Andreas ^a   HoeftSchröder, Stefan ^e  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Schiffahrtmedizinisches Institut der Marine   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

^e Academic Teaching Hospital of the Universities of Kiel   (Germany)

Author keywords

Apoptosis; Bcl 2; Caspase 3; Diving; Fas; Hyperbaric oxygen; Lymphocyte; Mitochondrion; Sepsis

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; FAS ANTIGEN; OXYGEN;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL MEMBRANE POTENTIAL; DNA FRAGMENTATION; HUMAN; HYPERBARIC OXYGEN; LEUKEMIA CELL LINE; LYMPHOCYTE; METABOLISM; MITOCHONDRION; SEPSIS;

ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; DNA FRAGMENTATION; HUMANS; HYPERBARIC OXYGENATION; JURKAT CELLS; LYMPHOCYTES; MEMBRANE POTENTIALS; MITOCHONDRIA; MODELS, BIOLOGICAL; OXYGEN; SEPSIS;

EID: 58949092518     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-008-0280-z     Document Type: Article

References (73)

1. Tibbles PM, Edelsberg JS (1996) Hyperbaric-oxygen therapy. N Engl J Med 334:1642-1648. doi:10.1056/NEJM199606203342506 (Pubitemid 26192525)
2. Frey G, Lampl L, Radermacher P, Bock KH (1998) Hyperbaric oxygenation. An area for the anesthetist? Anaesthesist 47:269-289. doi:10.1007/s001010050558 (Pubitemid 28206927)
3. Muth CM, Shank ES (2000) Gas embolism. N Engl J Med 342:476-482. doi:10.1056/NEJM200002173420706 (Pubitemid 30100236)
4. Leach RM, Rees PJ, Wilmshurst P (1998) Hyperbaric oxygen therapy. BMJ 317:1140-1143
5. Enoch S, Grey JE, Harding KG (2006) ABC of wound healing. Non-surgical and drug treatments. BMJ 332:900-903. doi:10.1136/bmj.332.7546.900 (Pubitemid 44365590)
6. Gill AL, Bell CN (2004) Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM 97:385-395. doi:10.1093/ qjmed/hch074 (Pubitemid 38967412)
7. Buras JA, Holt D, Orlow D, Belikoff B, Pavlides S, Reenstra WR (2006) Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism. Crit Care Med 34:2624-2629. doi:10.1097/01.CCM.0000239438.22758.E0 (Pubitemid 44413063)
8. Calzia E, Oter S, Muth CM, Radermacher P (2006) Evolving career of hyperbaric oxygen in sepsis: from augmentation of oxygen delivery to the modulation of the immune response. Crit Care Med 34:2693-2695. doi:10.1097/01.CCM.0000240782. 44414.3A (Pubitemid 44413082)
9. Oter S, Radermacher P, Matejovic M (2006) Can (hyperbaric) oxygen turn off the motor of multiorgan dysfunction? Intensive Care Med 32:1694-1696. doi:10.1007/s00134-006-0379-z (Pubitemid 44607355)
10. Muth CM, Radermacher P, Cuzzocrea S (2005) Hyperbaric oxygen and sepsis: time to recognize. Intensive Care Med 31:1150-1152. doi:10.1007/s00134-005-2700- 7 (Pubitemid 41355788)
11. Treacher DF, Leach RM (1998) Oxygen transport-1. Basic principles. BMJ 317:1302-1306
12. Granowitz EV, Skulsky EJ, Benson RM et al (2002) Exposure to increased pressure or hyperbaric oxygen suppresses interferongamma secretion in whole blood cultures of healthy humans. Undersea Hyperb Med 29:216-225
13. Benson RM, Minter LM, Osborne BA, Granowitz EV (2003) Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol 134:57-62. doi:10.1046/j.1365- 2249.2003.02248.x (Pubitemid 37186588)
14. Bitterman N, Bitterman H, Kinarty A, Melamed Y, Lahat N (1993) Effect of a single exposure to hyperbaric oxygen on blood mononuclear cells in human subjects. Undersea Hyperb Med 20:197-204
15. Bitterman N, Lahat N, Rosenwald T, Kinarty A, Melamed Y, Bitterman H (1994) Effect of hyperbaric oxygen on tissue distribution of mononuclear cell subsets in the rat. J Appl Physiol 77:2355-2359 (Pubitemid 24346445)
16. Groger M, Speit G, Radermacher P, Muth CM (2005) Interaction of hyperbaric oxygen, nitric oxide, and heme oxygenase on DNA strand breaks in vivo. Mutat Res 572:167-172. doi:10.1016/ j.mrfmmm.2005.01.015 (Pubitemid 40403664)
17. Speit G, Dennog C, Radermacher P, Rothfuss A (2002) Genotoxicity of hyperbaric oxygen. Mutat Res 512:111-119. doi:10.1016/S1383-5742(02)00045-5 (Pubitemid 35441050)
18. Rothfuss A, Radermacher P, Speit G (2001) Involvement of heme oxygenase-1 (HO-1) in the adaptive protection of human lymphocytes after hyperbaric oxygen (HBO) treatment. Carcinogenesis 22:1979-1985. doi:10.1093/carcin/22.12.1979 (Pubitemid 34065392)
19. Muth CM, Glenz Y, Klaus M, Radermacher P, Speit G, Leverve X (2004) Influence of an orally effective SOD on hyperbaricoxygen-related cell damage. Free Radic Res 38:927-932. doi:10.1080/10715760412331273197 (Pubitemid 39341688)
20. Speit G, Dennog C, Eichhorn U, Rothfuss A, Kaina B (2000) Induction of heme oxygenase-1 and adaptive protection against the induction of DNA damage after hyperbaric oxygen treatment. Carcinogenesis 21:1795-1799. doi:10.1093/carcin/21.10.1795
21. Gadd MA, McClellan DS, Neuman TS, Hansbrough JF (1990) Effect of hyperbaric oxygen on murine neutrophil and T-lymphocyte functions. Crit Care Med 18:974-979. doi:10.1097/ 00003246-199009000-00014 (Pubitemid 20312002)
22. Granowitz EV, Tonomura N, Benson RM et al (2005) Hyperbaric oxygen inhibits benign and malignant human mammary epithelial cell proliferation. Anticancer Res 25:3833-3842 (Pubitemid 41665152)
23. Won WD, Ross HC, Deig EF (1976) Influence of cold or hyperbaric helium-oxygen environments on mouse response to a respiratory viral infection. Aviat Space Environ Med 47:704-707
24. Won WD, Ross HC (1975) Catecholamine and phagocytic responses in infected mice exposed to hyperbaric helium-oxygen atmospheres. Aviat Space Environ Med 46:191-193
25. Jacobs BB, Thuning CA, Sacksteder MR, Warren J (1979) Extended skin allograft survival in mice during prolonged exposure to hyperbaric oxygen. Transplantation 28:70-72. doi:10.1097/00007890-197907000-00017 (Pubitemid 9229723)
26. Erdmann D, Roth AC, Hussmann J et al (1995) Skin allograft rejection and hyperbaric oxygen treatment in immune-histoincompatible mice. Undersea Hyperb Med 22:395-399
27. Erdmann D, Roth AC, Hussmann J et al (1996) Hyperbaric oxygen and cyclosporine as a combined treatment regimen to prevent skin allograft rejection in immunohistoincompatible mice. Ann Plast Surg 36:304-308. doi:10.1097/00000637- 199603000-00013 (Pubitemid 26088998)
28. Yin D, Zhou C, Kusaka I et al (2003) Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. J Cereb Blood Flow Metab 23:855-864. doi:10.1097/01.WCB.00000739 46.29308.55 (Pubitemid 36818693)
29. Ostrowski RP, Colohan AR, Zhang JH (2005) Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 25:554-571. doi:10.1038/sj.jcbfm.9600048 (Pubitemid 40562929)
30. Zhang Q, Chang Q, Cox RA, Gong X, Gould LJ (2008) Hyperbaric Oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol 128(8):2102-2112 (Pubitemid 352001230)
31. Conconi MT, Baiguera S, Guidolin D et al (2003) Effects of hyperbaric oxygen on proliferative and apoptotic activities and reactive oxygen species generation in mouse fibroblast 3T3/J2 cell line. J Investig Med 51:227-232. doi:10.2310/6650.2003. 39201 (Pubitemid 36870446)
32. Ganguly BJ, Tonomura N, Benson RM, Osborne BA, Granowitz EV (2002) Hyperbaric oxygen enhances apoptosis in hematopoietic cells. Apoptosis 7:499-510. doi:10.1023/A:1020686908831 (Pubitemid 35334444)
33. Chen YC, Chen SY, Ho PS et al (2007) Apoptosis of T-leukemia and B-myeloma cancer cells induced by hyperbaric oxygen increased phosphorylation of p38 MAPK. Leuk Res 31:805-815. doi:10.1016/j.leukres.2006.09.016 (Pubitemid 46855897)
34. Green DR, Ferguson TA (2001) The role of Fas ligand in immune privilege. Nat Rev Mol Cell Biol 2:917-924. doi:10.1038/ 35103104 (Pubitemid 33674091)
35. Krammer PH (2000) CD95's deadly mission in the immune system. Nature 407:789-795. doi:10.1038/35037728
36. Wajant H (2002) The Fas signaling pathway: more than a paradigm. Science 296:1635-1636. doi:10.1126/science.1071553 (Pubitemid 34579146)
37. Zamzami N, Kroemer G (2001) The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2:67-71. doi:10.1038/35048073 (Pubitemid 33676964)
38. Martinou JC, Green DR (2001) Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2:63-67. doi:10.1038/35048069 (Pubitemid 33676963)
39. Willis SN, Adams JM (2005) Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17:617-625. doi:10.1016/j.ceb.2005.10.001 (Pubitemid 41540411)
40. Rasola A, Bernardi P (2007) The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12:815-833. doi:10.1007/s10495-007- 0723-y (Pubitemid 46653292)
41. Kim HE, Du F, Fang M, Wang X (2005) Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci USA 102:17545-17550. doi:10.1073/pnas.0507900102 (Pubitemid 41803534)
42. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770-776. doi:10.1038/35037710
43. Nicholson DW, Ali A, Thornberry NA et al (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43. doi:10.1038/376037a0
44. Schneider U, Schwenk HU, Bornkamm G (1977) Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 19:621-626. doi:10.1002/ijc.2910190505 (Pubitemid 8094638)
45. Martin DA, Siegel RM, Zheng L, Lenardo MJ (1998) Membrane oligomerization and cleavage activates the caspase-8 (FLICE/ MACHalpha1) death signal. J Biol Chem 273:4345-4349. doi:10.1074/jbc.273.8.4345 (Pubitemid 28103169)
46. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312-1316. doi:10.1126/science.281.5381.1312 (Pubitemid 28406817)
47. Milanesi E, Costantini P, Gambalunga A et al (2006) The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2, 4, 6-trione derivative. J Biol Chem 281:10066-10072. doi:10.1074/ jbc.M513708200 (Pubitemid 43864541)
48. Ettorre A, Andreassi M, Anselmi C, Neri P, Andreassi L, Di Stefano A (2003) Involvement of oxidative stress in apoptosis induced by a mixture of isothiazolinones in normal human keratinocytes. J Invest Dermatol 121:328-336. doi:10.1046/j.1523- 1747.2003.12360.x (Pubitemid 36969907)
49. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279. doi:10.1016/0022- 1759(91) 90198-O
50. Smiley ST, Reers M, Mottola-Hartshorn C et al (1991) Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA 88:3671-3675. doi:10.1073/pnas.88.9.3671 (Pubitemid 21916685)
51. Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M, Chen LB (1995) Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 260:406-417. doi:10.1016/0076-6879(95) 60154-6
52. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5, 50, 6, 60-tetrachloro-1, 10, 3, 30-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 197:40-45. doi:10.1006/bbrc.1993.2438 (Pubitemid 23358874)
53. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310. doi:10.1097/00003246- 200107000-00002 (Pubitemid 32641789)
54. Brun-Buisson C (2000) The epidemiology of the systemic inflammatory response. Intensive Care Med 26(Suppl 1):S64-S74. doi:10.1007/s001340051121 (Pubitemid 30184495)
55. Brunkhorst FM (2006) Epidemiology, economy and practice- results of the German study on prevalence by the competencenetwork sepsis (SepNet) [Epidemiologie, Okonomie und Praxis-Ergebnisse der deutschen Pravalenzstudie des Kompetenznetzwerkes Sepsis (SepNet)]. Anasthesiol Intensivmed Notfallmed Schmerzther 41(1):43-44 (Pubitemid 43189493)
56. Hotchkiss RS, Chang KC, Swanson PE et al (2000) Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 1:496-501. doi:10.1038/82741
57. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis.NEngl J Med 348:138-150. doi:10.1056/NEJMra021333 (Pubitemid 36056721)
58. Perl M, Chung CS, Ayala A (2005) Apoptosis. Crit Care Med 33:S526-S529. doi:10.1097/01.CCM.0000185499.28006.4C (Pubitemid 41786008)
59. Salmena L, Lemmers B, Hakem A et al (2003) Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 17(7):883-895 Epub 2003 Mar 21 (Pubitemid 36397376)
60. Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626-629. doi:10.1126/science. 1099320 (Pubitemid 39006738)
61. Green DR, Kroemer G (2005) Pharmacological manipulation of cell death: clinical applications in sight? J Clin Invest 115:2610-2617. doi:10.1172/JCI26321 (Pubitemid 41434383)
62. Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IE (2005) Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol 174:5110-5118
63. Wada K, Miyazawa T, Nomura N et al (2000) Mn-SOD and Bcl- 2 expression after repeated hyperbaric oxygenation. Acta Neurochir Suppl (Wien) 76:285-290
64. Tonomura N, Granowitz EV (2007) Hyperbaric oxygen: a potential new therapy for leukemia? Leuk Res 31:745-746. doi:10.1016/j.leukres.2006.11.020 (Pubitemid 46855905)
65. Halliwell B (2003) Oxidative stress in cell culture: an underappreciated problem? FEBS Lett 540:3-6. doi:10.1016/S0014- 5793(03)00235-7 (Pubitemid 36398024)
66. Halliwell B, Cross CE (1994) Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 102(Suppl 10):5-12. doi:10.2307/3432205
67. Cross CE, Valacchi G, Schock B et al (2002) Environmental oxidant pollutant effects on biologic systems: a focus on micronutrient antioxidant-oxidant interactions. Am J Respir Crit Care Med 166:S44-S50. doi:10.1164/rccm.2206015 (Pubitemid 36015936)
68. Vissers MC, Wilkie RP (2007) Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1alpha. J Leukoc Biol 81:1236-1244. doi:10.1189/jlb.0806541 (Pubitemid 46702042)
69. Weinmann M, Marini P, Jendrossek V et al (2004) Influence of hypoxia on TRAIL-induced apoptosis in tumor cells. Int J Radiat Oncol Biol Phys 58:386-396. doi:10.1016/j.ijrobp.2003.09.052 (Pubitemid 38142463)
70. Bader N, Bosy-Westphal A, Koch A et al (2007) Effect of hyperbaric oxygen and vitamin C and E supplementation on biomarkers of oxidative stress in healthy men. Br J Nutr 98:826-833. doi:10.1017/S0007114507744380 (Pubitemid 47487952)
71. Ferrer MD, Sureda A, Batle JM, Tauler P, Tur JA, Pons A (2007) Scuba diving enhances endogenous antioxidant defenses in lymphocytes and neutrophils. Free Radic Res 41:274-281. doi:10.1080/10715760601080371 (Pubitemid 46404469)
72. Benedetti S, Lamorgese A, Piersantelli M, Pagliarani S, Benvenuti F, Canestrari F (2004) Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen. Clin Biochem 37:312-317. doi:10.1016/j.clinbiochem.2003. 12.001 (Pubitemid 38314886)
73. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B (2007) Mitochondria, oxidative stress and cell death. Apoptosis 12:913-922. doi:10.1007/s10495-007- 0756-2 (Pubitemid 46653300)